Table: Fuji Pharmaceutical - 6-MTH group results

Fuji Pharma

12/05/2026 08:30

May 12 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Mar 31, 2026        Mar 31, 2025     Sep 30, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.72               24.10            59.25    
                 (+23.3 pct)         (+12.7 pct)      (+14.7 pct) 
  Operating          4.40                2.31             6.12    
                 (+90.8 pct)         (+59.7 pct)      (+22.6 pct) 
  Recurring          4.26                2.21             5.88    
                 (+92.9 pct)         (+2.0 pct)       (+31.9 pct) 
  Net              713 mln               1.29             2.24    
                 (-44.6 pct)         (-69.8 pct)      (-25.3 pct) 
  EPS             28.75 yen           52.83 yen        91.54 yen  
  Ann Div                             45.50 yen        49.00 yen  
  -Q2 div         23.00 yen           20.00 yen                   
  -Q4 div                             25.50 yen        26.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T